# Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma

> **NCT02359097** · NA · COMPLETED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 29 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **PROCEDURE:** Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
- **DRUG:** Ferumoxytol
- **DRUG:** Gadoteridol
- **PROCEDURE:** Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT02359097
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-06
- **Primary completion:** 2021-03-12
- **Final completion:** 2021-03-12
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2022-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02359097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02359097, "Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02359097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*